As CF treatment duration extends, registry-based analyses will need to track pathogen-specific trends and long-term disease ...

China’s National Medical Products Administration (NMPA) has granted approval for four-weekly intravenous (IV) maintenance ...

Oral liquid drugs play a vital role for patients who have difficulty swallowing tablets and for those requiring personalised ...

Johnson & Johnson's Tremfya is the first IL-23 inhibitor to gain FDA approval in a paediatric population for plaque psoriasis ...

More than two-thirds – 67% - of first responders organisations have deployed new cybersecurity protections in the last 12 ...

The US FDA has expanded the approval of Regeneron Pharmaceuticals' fully human monoclonal antibody, Evkeeza (evinacumab-dgnb) ...

Amgen has revealed a significant investment plan, earmarking $650m to enhance its manufacturing operations in the US.

After demonstrating that its gene therapy can slash Huntington's disease progression by 75%, Uniqure will now file for ...

Evaxion’s preclinical asset targets an unknown infectious disease in which there are no other vaccines available.

Lithuania is rapidly growing as a leading force in the European life sciences scene, with over 400 life sciences companies in ...

Lilly has received approval from the US Food and Drug Administration (FDA) for Inluriyo (imlunestrant) to treat advanced ...

The 100% rate on imported, branded pharma products will not apply to drugmakers constructing manufacturing facilities in the ...